Author: Tom Wilemon
Grant strengthens breast cancer research efforts
Aug. 22, 2019—Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.
Potential second-line melanoma treatment identified
Aug. 15, 2019—A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.
Protein’s role in inflammation-related cancer studied
Aug. 15, 2019—Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.
Shu, Zheng receive Vietnam’s top honor for foreign scientists
Aug. 1, 2019—The Vietnamese Ministry of Health has awarded two Vanderbilt epidemiologists the Memorabilia Medal “For the People’s Health” in appreciation of their contributions in helping the nation establish a population-based research program for cancer, diabetes and other non-communicable diseases.
Grant bolsters research on myelodysplastic syndromes
Aug. 1, 2019—Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.
Encephalitis identified as rare toxicity of immunotherapy treatment
Jul. 22, 2019—Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.
Center for Immunobiology grows, bolsters program
Jul. 18, 2019—The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.
Health disparity for blacks exists within lung screening guidelines
Jun. 26, 2019—The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans are excluding significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications to lung cancer screening criteria, according to a study from Vanderbilt researchers.
Biomarkers of DNA methylation can be a predictor of breast cancer risk
Jun. 26, 2019—Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
Study identifies critical regulator of tumor-specific T cell differentiation
Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work
DBS treatment may slow tremor progression in early-stage Parkinson’s patients
Jun. 29, 2018—Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may possibly delay the progression of...
Study tracks psychological intervention for ACL rehab
Jun. 28, 2018—Professional athletes like Tom Brady, Derrick Rose and Megan Rapinoe had the grit to stay in the game after suffering anterior cruciate ligament (ACL) tears, but the knee injury is often a career-ender for others.